The natural history of sclerosteosis.

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med (2004) 3.88

Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease. Genome Res (2005) 2.61

Sclerostin: current knowledge and future perspectives. Calcif Tissue Int (2010) 1.71

Wnt signaling as a therapeutic target for bone diseases. Expert Opin Ther Targets (2009) 1.61

Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation. J Biol Chem (2009) 1.60

Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. J Biol Chem (2010) 1.38

Fracture healing: mechanisms and interventions. Nat Rev Rheumatol (2014) 1.33

Serum sclerostin and risk of hip fracture in older Caucasian women. J Clin Endocrinol Metab (2012) 1.08

High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes. Bone (2011) 1.05

'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass. Osteoporos Int (2011) 1.03

Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors. J Biol Chem (2012) 1.01

Circulating sclerostin in disorders of parathyroid gland function. J Clin Endocrinol Metab (2011) 0.96

Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy. Am J Stem Cells (2012) 0.95

Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases. Ther Adv Musculoskelet Dis (2014) 0.94

Impact of inflammation on the osteoblast in rheumatic diseases. Curr Osteoporos Rep (2014) 0.92

Sclerostin Inhibition in the Management of Osteoporosis. Calcif Tissue Int (2016) 0.92

Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner. Dev Biol (2013) 0.89

High bone mass is associated with an increased prevalence of joint replacement: a case-control study. Rheumatology (Oxford) (2013) 0.87

Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskelet Dis (2016) 0.86

Analysis of body composition in individuals with high bone mass reveals a marked increase in fat mass in women but not men. J Clin Endocrinol Metab (2013) 0.85

Bone metabolic activity in hyperostosis cranialis interna measured with 18F-fluoride PET. Eur J Nucl Med Mol Imaging (2010) 0.84

Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia. Hum Genet (2011) 0.84

Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management. Rheumatology (Oxford) (2013) 0.84

Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23. Matrix Biol (2015) 0.81

Osteogenic inhibition in multiple myeloma. Cell J (2013) 0.79

Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts. Clin Rev Allergy Immunol (2016) 0.78

Osteoarthritis and bone mineral density: are strong bones bad for joints? Bonekey Rep (2015) 0.76

Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges. J Osteoporos (2016) 0.76

Co-expression of DKK-1 and Sclerostin in Subchondral Bone of the Proximal Femoral Heads from Osteoarthritic Hips. Calcif Tissue Int (2017) 0.75

Differential expression of sclerostin in adult and juvenile mouse calvariae. Plast Reconstr Surg (2011) 0.75

Sclerosterosis (Truswell-Hansen disease). Indian J Hum Genet (2013) 0.75

Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo. Mol Ther Nucleic Acids (2016) 0.75

Management of trigeminal neuralgia in sclerosteosis. Surg Neurol Int (2013) 0.75

Osteoblasts as leukemia-initiating cells. Bonekey Rep (2014) 0.75

Positioning novel biologicals in CKD-mineral and bone disorders. J Nephrol (2017) 0.75

Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation. PLoS One (2017) 0.75

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99

A receptor kinase-like protein encoded by the rice disease resistance gene, Xa21. Science (1995) 9.79

Articular mobility in an African population. Ann Rheum Dis (1973) 7.01

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97

Orthopaedic aspects of the Ehlers-Danlos syndrome. J Bone Joint Surg Br (1969) 3.30

Biochemical studies on adenovirus multiplication, XIX. Resolution of late viral RNA species in the nucleus and cytoplasm. Proc Natl Acad Sci U S A (1971) 3.02

Evolution of the rice Xa21 disease resistance gene family. Plant Cell (1997) 2.56

Detection of a high frequency RsaI polymorphism in the human pro alpha 2(I) collagen gene which is linked to an autosomal dominant form of osteogenesis imperfecta. EMBO J (1985) 2.52

Implications of supervision registers in psychiatry. BMJ (1994) 2.22

Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. Am J Hum Genet (1990) 2.11

Long-term memory of body weight and past weight satisfaction: a longitudinal follow-up study. Am J Clin Nutr (1991) 2.07

Radial ray defects and associated anomalies. Clin Genet (1989) 2.06

Rheumatoid arthritis in a rural South African Negro population. Ann Rheum Dis (1975) 2.03

Help! Unusual X-ray appearances of a congenital bone disease of unknown aetiology. Pediatr Radiol (2001) 2.01

Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet (2000) 1.98

Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Am J Hum Genet (1992) 1.94

Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision, is assigned to chromosome region 11q12-13. Am J Hum Genet (1996) 1.89

A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. Transplantation (1999) 1.88

During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J Virol (2004) 1.84

Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet (2001) 1.81

Osteoglophonic dwarfism. Pediatr Radiol (1980) 1.76

Surgical aspects of the Ehlers-Danlos syndrome. A survey of 100 cases. Br J Surg (1969) 1.72

The effectiveness of housing policies in reducing children's lead exposure. Am J Public Health (2001) 1.70

The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals. Ann Intern Med (1976) 1.63

Accuracy of recall by middle-aged participants in a longitudinal study of their body size and indices of maturation earlier in life. Ann Hum Biol (1991) 1.62

Accuracy of recalled smoking data. Am J Public Health (1989) 1.61

Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients. Ann Rheum Dis (1969) 1.59

The syndromic status of sclerosteosis and van Buchem disease. Clin Genet (1984) 1.58

Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58

Rheumatic disorders in the South African Negro. Part II. Osteo-arthrosis. S Afr Med J (1975) 1.57

A new locus for autosomal dominant retinitis pigmentosa on the short arm of chromosome 17. Hum Mol Genet (1994) 1.56

A review of the osteopetroses. Postgrad Med J (1977) 1.53

Vestibular dysfunction in hereditary ataxia. Brain (1975) 1.53

Sclerosteosis - an autosomal recessive disorder. Clin Genet (1977) 1.50

Mutations in Sox18 underlie cardiovascular and hair follicle defects in ragged mice. Nat Genet (2000) 1.50

Structure, expression and chromosomal mapping of c-akt: relationship to v-akt and its implications. Oncogene (1993) 1.49

The dominant and recessive forms of cutis laxa. J Med Genet (1972) 1.48

Circumstances of post-neonatal deaths in Ceara, Northeast Brazil: mothers' health care-seeking behaviors during their infants' fatal illness. Soc Sci Med (2000) 1.46

Blood-pressure and its correlates in urban and tribal Africa. Lancet (1980) 1.40

Value Health sells Lewin unit to avoid contract loss. Mod Healthc (1995) 1.39

Congenital hypertrichosis lanuginosa. Arch Dermatol (1970) 1.39

Lethal complications of the Ehlers-Danlos syndrome. Br Med J (1968) 1.39

The HIPAA lurks. Just when CIOs thought it was safe for business as usual.... Mod Healthc (2000) 1.38

Familial dentinogenesis imperfecta, blue sclerae, and wormian bones without fractures: another type of osteogenesis imperfecta? J Med Genet (1981) 1.38

THE CAROTENE AND ASCORBIC ACID CONCENTRATION OF VEGETABLE VARIETIES. Plant Physiol (1944) 1.37

Physical properties of the skin in the Ehlers-Danlos syndrome. Ann Rheum Dis (1969) 1.36

Leukocyte telomere length is associated with cognitive performance in healthy women. Neurobiol Aging (2008) 1.36

Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J Gen Virol (1994) 1.35

Rheumatoid arthritis in a tribal Xhosa population in the Transkei, Southern Africa. Ann Rheum Dis (1977) 1.34

Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity? Br J Cancer (2007) 1.32

Crouzonodermoskeletal syndrome. J Clin Pediatr Dent (2004) 1.30

Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology (1998) 1.30

Regional brain chemical alterations in young children with autism spectrum disorder. Neurology (2003) 1.30

Osteoarthrosis in a rural South African Negro population. Ann Rheum Dis (1976) 1.29

Sclerosteosis in South Africa. S Afr Med J (1979) 1.29

Memory of food intake in the distant past. Am J Epidemiol (1989) 1.28

The ocular form of osteogenesis imperfecta: a new autosomal recessive syndrome. Clin Genet (1985) 1.27

Proteus syndrome in southern Africa: natural history and clinical manifestations in six individuals. Am J Med Genet (1987) 1.27

X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats. Am J Hum Genet (1999) 1.26

HLA associations in sarcoidosis: a study of two ethnic groups. Thorax (1984) 1.25

Molecular mechanisms of sequestration in malaria. Parasitology (1994) 1.25

Prodromal trigeminal sensory neuropathy in progressive systemic sclerosis. Ann Rheum Dis (1968) 1.23

Wormian bones in osteogenesis imperfecta and other disorders. Skeletal Radiol (1982) 1.21

Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol (1989) 1.21

The fragile X chromosome in a large Indian kindred. Clin Genet (1983) 1.18

LATS activity, exophthalmos and digital clubbing associated with myxoedema. Postgrad Med J (1968) 1.18

Delta F508 testing of the DNA bank of the Royal Manchester Children's Hospital. Hum Genet (1990) 1.18

A comparison of food frequency and diet recall methods in studies of nutrient intake of low-income pregnant women. J Am Diet Assoc (1989) 1.18

Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism. Am J Hum Genet (1992) 1.17

Acquired cutis laxa. Primary generalized elastolysis. Arch Dermatol (1971) 1.16

Articular manifestations of the Ehlers-Danlos Syndrome. Semin Arthritis Rheum (1972) 1.16

Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc Natl Acad Sci U S A (1995) 1.14

Autosomal dominant (Beukes) premature degenerative osteoarthropathy of the hip joint maps to an 11-cM region on chromosome 4q35. Am J Hum Genet (1999) 1.14

Autosomal recessive inheritance of osteogenesis imperfecta. Clin Genet (1975) 1.14

Osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Clin Genet (1989) 1.14

Evidence for genetic heterogeneity in tuberous sclerosis. J Med Genet (1989) 1.14

Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I. J Med Genet (1986) 1.14

Dysplasia epiphysialis hemimelica. A clinical and genetic study. J Bone Joint Surg Br (1983) 1.13

Calcium dependence of calcium extrusion and calcium uptake in mouse pancreatic acinar cells. J Physiol (1996) 1.13

X-linked mixed deafness with stapes fixation in a Mauritian kindred: linkage to Xq probe pDP34. Genomics (1988) 1.13

The manifestations and natural history of spondylo-epi-metaphyseal dysplasia with joint laxity. Clin Genet (1984) 1.11

Plastic surgery in pseudoxanthoma elasticum: experience in nine patients. Plast Reconstr Surg (1990) 1.11

Differences in the outcomes of acute episodes of care provided by various types of family practitioners. J Fam Pract (1978) 1.09

Familial hypertrichosis cubiti: hairy elbows syndrome. J Med Genet (1970) 1.09

Spondyloepiphyseal dysplasia, mild autosomal dominant type is not due to primary defects of type II collagen. Am J Med Genet (1990) 1.09

Two rare developmental defects of the lower limbs with confirmation of the Lewin and Opitz hypothesis on the fibular and tibial developmental fields. Am J Med Genet (1989) 1.08

Acute oxalate nephropathy after a massive intravenous dose of vitamin C. Aust N Z J Med (1994) 1.08

The radiology of sclerosteosis. Br J Radiol (1976) 1.08

Spondylo-epi-metaphyseal dysplasia with joint laxity and severe, progressive kyphoscoliosis. Skeletal Radiol (1980) 1.08

The serine proteinase inhibitor (serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon alpha/beta priming. J Exp Med (1998) 1.08

Gaucher disease in the Afrikaner population of South Africa. S Afr Med J (1979) 1.07

Cutaneous manifestations of Gaucher disease. Br J Dermatol (1984) 1.07

Serum uric acid concentrations in an urbanized South African Negro population. Ann Rheum Dis (1974) 1.06

Linkage studies of X-linked mental retardation: high frequency of recombination in the telomeric region of the human X chromosome (fragile site/linkage/recombination/X chromosome). Hum Genet (1985) 1.06

Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1p34-p36.1 by homozygosity mapping. Hum Mol Genet (1995) 1.05

Arbovirus of marine mammals: a new alphavirus isolated from the elephant seal louse, Lepidophthirus macrorhini. J Virol (2001) 1.04

Isolation of a human T-lymphotropic virus type I strain from Australian aboriginals. J Virol (1993) 1.04

Atelosteogenesis. Am J Med Genet (1982) 1.04

Inducibility of transferrin receptors on friend erythroleukemic cells. Science (1977) 1.04